Advertisement

A bridge between neurology and psychiatry

Published:October 30, 2016DOI:https://doi.org/10.1016/j.yebeh.2016.08.017
      I was born in 1935 in Caerleon, a village in Monmouthshire, South Wales, but formerly a “city” on the edge of the Roman Empire known as Isca Salurium, where the second Legion of Augustus was based. Perhaps this kindled in me an enduring interest in history. I was the eldest of three siblings of a Welsh father and Irish mother. My father was the village general practitioner and two uncles were also doctors, which clearly influenced my choice of a medical career. My earliest memories included 1) accompanying my father to rural surgeries and patients and 2) an awareness of the Second World War while at a boarding school in Weston-super-mare, Somerset, where I had been sent to be exposed to sea air for my childhood asthma. After the War, I moved on to the Oratory School in Berkshire, where my greatest achievement was playing cricket for the school at the famous Lord's Cricket Ground in London in the days, long gone, when a few privileged schools were allowed to hold an annual match there.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Epilepsy & Behavior
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Reynolds E.H.
        Mental effects of anticonvulsant drugs and folate metabolism.
        Brain. 1968; 91: 197-214
        • Peck A.W.
        Lamotrigine: historical background.
        Rev Contemp Pharmacother. 1994; 5: 95-105
        • Reynolds E.H.
        Chronic antiepileptic toxicity: a review.
        Epilepsia. 1975; 16: 319-352
        • Trimble M.R.
        • Reynolds E.H.
        Anticonvulsant drugs and mental symptoms: a review.
        Psychol Med. 1976; 6: 169-178
        • Reynolds E.H.
        • Shorvon S.D.
        Monotherapy or polytherapy for epilepsy?.
        Epilepsia. 1981; 22: 1-10
        • Heller A.J.
        • Chesterman P.
        • Elwes R.D.C.
        • Crawford P.
        • Chadwick D.
        • Johnson A.L.
        • et al.
        Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial.
        J Neurol Neurosurg Psychiatry. 1995; 58: 44-50
        • de Silva M.
        • McArdle B.
        • McGowan M.
        • Hughes E.
        • Stewart J.
        • Neville B.G.R.
        • et al.
        Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy.
        Lancet. 1996; 347: 709-713
        • Reynolds E.H.
        Treating refractory epilepsy in adults.
        BMJ. 2006; 332: 562-563
        • Reynolds E.H.
        • Elwes R.D.C.
        • Shorvon S.D.
        Why does epilepsy become intractable? Prevention of chronic epilepsy.
        Lancet. 1983; ii: 952-954
        • Reynolds E.H.
        The early treatment and prognosis of epilepsy.
        Epilepsia. 1987; 28: 97-106
        • Reynolds E.
        Vitamin B12, folic acid, and the nervous system.
        Lancet Neurol. 2006; 5: 949-960
        • Reynolds E.H.
        The neurology of folic acid deficiency.
        in: Biller J. Ferro A.M. Handbook of clinical neurology. vol. 120 (third series). 2014: 927-943
        • Reynolds E.H.
        The Institute of Epileptology of King's College, University of London.
        Epilepsia. 1995; 36: S4-S7
        • Jallon P.
        Epilepsy in developing countries: ILAE workshop report.
        Epilepsia. 1997; 38: 1143-1151
        • Reynolds E.H.
        ILAE/IBE/WHO/global campaign “Out of the shadows”: global and regional developments.
        Epilepsia. 2001; 42: 1094-1100
      1. Reynolds E.H. Epilepsy in the world: launch of the second phase of the ILAE/IBE/WHO Global Campaign against Epilepsy. Epilepsia. 43. 2002 (suppl 6)
        • Covanis A.
        • Guekht A.
        • Li S.
        • Secco M.
        • Shakir R.
        • Perruca E.
        From global campaign to global commitment: the World Health Assembly's resolution on epilepsy.
        Epilepsia. 2015; 56: 1651-1657
        • Reynolds E.H.
        • Trimble M.R.
        The bridge between neurology and psychiatry.
        Churchill Livingstone, Edinburgh1989
        • Reynolds E.H.
        Structure and function in neurology and psychiatry.
        Brit J Psychiatry. 1990; 157: 481-490
        • Reynolds E.H.
        The historical evolution and future of neurology and psychiatry.
        J Neurol Neurosurg Psychiatry. 2015; 86: 1386-1388
        • Reynolds E.H.
        Brain and mind: a challenge for WHO.
        Lancet. 2003; 361: 1924-1925
        • Reynolds E.H.
        Jackson, Todd, and the concept of “discharge” in epilepsy.
        Epilepsia. 2007; 48: 2016-2022
        • Kinnier Wilson J.V.
        • Reynolds E.H.
        Translation and analysis of a cuneiform text forming part of a Babylonian treatise on epilepsy.
        Med Hist. 1990; 34: 185-198
        • Reynolds E.H.
        • Kinnier Wilson J.V.
        Neurology and psychiatry in Babylon.
        Brain. 2014; 137: 2611-2619
        • Reynolds E.H.
        Milestones in epilepsy.
        Epilepsia. 2009; 50: 338-342
        • Reynolds E.H.
        • Trimble M.R.
        Epilepsy, psychiatry and neurology.
        Epilepsia. 2009; 50: 50-55
        • Trimble M.R.
        • Reynolds E.H.
        What is epilepsy? The clinical and scientific basis of epilepsy.
        Churchill Livingstone, Edinburgh1986
        • Reynolds E.H.
        • Rodin E.
        The clinical concept of epilepsy.
        Epilepsia. 2009; 50: 2-7